Prosecution Insights
Prosecution Insights
6 pending office actions • 3 clients • 6 examiners • 6 art units • 0 of 6 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| §102 only | 1 (17%) |
| §112 only | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DAVIS, BRIAN J | 1 | 84.9% | -4.4% |
| OGUNBIYI, OLUWATOSIN A | 1 | 63.3% | +42.1% |
| WORSHAM, JESSICA N | 1 | 56.6% | +57.0% |
| COUGHLIN, MATTHEW P | 1 | 71.3% | +11.8% |
| GURLEY, JAMI MICHELLE | 1 | 45.0% | +25.5% |
| CLARKE, TRENT R | 1 | 41.2% | +26.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18285439 | IMMUNOFUNCTIONAL CARRIER, METHODS OF USES, AND COMPOSITION MATTERS AS AN ANTITUMOR IMMUNOTHERAPY | DAVIS, BRIAN J | 3d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17409962 | METHOD AND COMPOSITION AGAINST VIRUS INFECTIONS WITH ACTIVATED INNATE LYMPHOID CELLS (ILCS) | CLARKE, TRENT R | 74d overdue |
| 17794917 | LIGAND-MEDIATED DELIVERY OF THERAPEUTIC PROTEINS AND THE USES THEREOF | GURLEY, JAMI MICHELLE | 53d overdue |
| 18034969 | NON-CATIONIC SOFT POLYPHENOL NANOCAPSULES FOR EFFECTIVE SYSTEMIC DELIVERY OF SMALL INTERFERING RNA (siRNA) FOR CANCER TREATMENT | WORSHAM, JESSICA N | 44d overdue |
| 18123018 | Circularly Recyclable Polymers Featuring Topochemically Elongated Carbon-Carbon Bonds | COUGHLIN, MATTHEW P | 36d overdue |
| 18550036 | NOVEL VACCINE FORMULATIONS FOR MYCOBACTERIUM TUBERCULOSIS AND USE OF THEREOF | OGUNBIYI, OLUWATOSIN A | 17d overdue |
| Client (Assignee) | Pending OAs |
|---|---|
| PURDUE RESEARCH FOUNDATION | 4 |
| Houston Methodist | 1 |
| U.S. Government | 1 |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| 1645 | 1 |
| 1615 | 1 |
| 1626 | 1 |
| 1647 | 1 |
| 1651 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18285439 | IMMUNOFUNCTIONAL CARRIER, METHODS OF USES, AND COMPOSITION MATTERS AS AN ANTITUMOR IMMUNOTHERAPY | Purdue Research Foundation | DAVIS, BRIAN J | 1614 | §102 | Final Rejection | 3d overdue | Pending | Oct 03, 2023 |
| 18550036 | NOVEL VACCINE FORMULATIONS FOR MYCOBACTERIUM TUBERCULOSIS AND USE OF THEREOF | Houston Methodist Research Institute | OGUNBIYI, OLUWATOSIN A | 1645 | §103 | Non-Final OA | 17d overdue | Pending | Sep 11, 2023 |
| 18034969 | NON-CATIONIC SOFT POLYPHENOL NANOCAPSULES FOR EFFECTIVE SYSTEMIC DELIVERY OF SMALL INTERFERING RNA (siRNA) FOR CANCER TREATMENT | Purdue Research Foundation | WORSHAM, JESSICA N | 1615 | §103 | Non-Final OA | 44d overdue | Pending | May 02, 2023 |
| 18123018 | Circularly Recyclable Polymers Featuring Topochemically Elongated Carbon-Carbon Bonds | Purdue Research Foundation | COUGHLIN, MATTHEW P | 1626 | §112 | Non-Final OA | 36d overdue | Pending | Mar 17, 2023 |
| 17794917 | LIGAND-MEDIATED DELIVERY OF THERAPEUTIC PROTEINS AND THE USES THEREOF | Purdue Research Foundation | GURLEY, JAMI MICHELLE | 1647 | §103 | Non-Final OA | 53d overdue | Pending | Jul 22, 2022 |
| 17409962 | METHOD AND COMPOSITION AGAINST VIRUS INFECTIONS WITH ACTIVATED INNATE LYMPHOID CELLS (ILCS) | The United States Of America, AS Represented By The Secretary, Department Of Hhs | CLARKE, TRENT R | 1651 | §112 | Final Rejection | 74d overdue | Pending | Aug 24, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial